AAPL   380.18 (-0.31%)
MSFT   212.09 (-0.35%)
FB   240.07 (-1.44%)
GOOGL   1,500.48 (-0.21%)
AMZN   3,087.46 (+0.21%)
NVDA   410.60 (+0.48%)
CGC   15.78 (-3.37%)
BABA   257.08 (-0.23%)
MU   48.95 (-1.53%)
GE   6.63 (-3.35%)
TSLA   1,361.13 (-0.35%)
AMD   54.99 (+2.92%)
T   29.42 (-3.45%)
ACB   11.49 (-5.59%)
GILD   74.60 (-1.34%)
DIS   116.06 (-0.51%)
BAC   22.49 (-2.64%)
NFLX   496.73 (-1.20%)
BA   174.07 (-3.34%)
AAPL   380.18 (-0.31%)
MSFT   212.09 (-0.35%)
FB   240.07 (-1.44%)
GOOGL   1,500.48 (-0.21%)
AMZN   3,087.46 (+0.21%)
NVDA   410.60 (+0.48%)
CGC   15.78 (-3.37%)
BABA   257.08 (-0.23%)
MU   48.95 (-1.53%)
GE   6.63 (-3.35%)
TSLA   1,361.13 (-0.35%)
AMD   54.99 (+2.92%)
T   29.42 (-3.45%)
ACB   11.49 (-5.59%)
GILD   74.60 (-1.34%)
DIS   116.06 (-0.51%)
BAC   22.49 (-2.64%)
NFLX   496.73 (-1.20%)
BA   174.07 (-3.34%)
AAPL   380.18 (-0.31%)
MSFT   212.09 (-0.35%)
FB   240.07 (-1.44%)
GOOGL   1,500.48 (-0.21%)
AMZN   3,087.46 (+0.21%)
NVDA   410.60 (+0.48%)
CGC   15.78 (-3.37%)
BABA   257.08 (-0.23%)
MU   48.95 (-1.53%)
GE   6.63 (-3.35%)
TSLA   1,361.13 (-0.35%)
AMD   54.99 (+2.92%)
T   29.42 (-3.45%)
ACB   11.49 (-5.59%)
GILD   74.60 (-1.34%)
DIS   116.06 (-0.51%)
BAC   22.49 (-2.64%)
NFLX   496.73 (-1.20%)
BA   174.07 (-3.34%)
AAPL   380.18 (-0.31%)
MSFT   212.09 (-0.35%)
FB   240.07 (-1.44%)
GOOGL   1,500.48 (-0.21%)
AMZN   3,087.46 (+0.21%)
NVDA   410.60 (+0.48%)
CGC   15.78 (-3.37%)
BABA   257.08 (-0.23%)
MU   48.95 (-1.53%)
GE   6.63 (-3.35%)
TSLA   1,361.13 (-0.35%)
AMD   54.99 (+2.92%)
T   29.42 (-3.45%)
ACB   11.49 (-5.59%)
GILD   74.60 (-1.34%)
DIS   116.06 (-0.51%)
BAC   22.49 (-2.64%)
NFLX   496.73 (-1.20%)
BA   174.07 (-3.34%)
Log in

7 Great Biotech Stocks That Don’t Depend on a Coronavirus Cure in 2020

 
7 Great Biotech Stocks That Don’t Depend on a Coronavirus CureBiotech stocks are some of the most volatile for investors to include in their portfolio. And that volatility can be hard to predict. Biotech companies don’t have a firm correlation with the overall economy. And what can add to the challenge is that many of these companies are small-cap companies that are not well-known names.

These small biotech stocks may shoot higher based on a vaccine or drug candidate that gets national attention. But these small-cap stock also reflect the adage of letting the buyer beware. Because the stark reality for many investors is that the vast majority of these treatments never make it past clinical trials. And that means that a stock that goes up rapidly can move down just as fast. We’re seeing that right now with the multitude of companies that are competing in the race towards a vaccine and/or treatment for Covid-19 and the novel coronavirus that causes the disease. And if you’ve been good at timing the market, you could have made some good money on some of these candidates.

Of course, if you held the stock too long, you could have lost your shirt as well.

That doesn’t mean however that buy and hold investors should avoid the biotech sector altogether. There are still some attractively priced small-cap biotech companies that are working on treatments for a range of conditions that provide them with a large addressable base. And we’ve identified seven of these stocks in this special presentation.

Click the "Continue to Slide #1" button to view the first company.




30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.